TY - JOUR T1 - Risk factors for severe disease in patients admitted with COVID-19 to a hospital in London, England: a retrospective cohort study JF - medRxiv DO - 10.1101/2020.09.24.20200337 SP - 2020.09.24.20200337 AU - J. W. Goodall AU - T. A. N. Reed AU - M. Ardissino AU - P. Bassett AU - A. M. Whittington AU - D. L. Cohen AU - N. Vaid Y1 - 2020/01/01 UR - http://medrxiv.org/content/early/2020/09/25/2020.09.24.20200337.abstract N2 - COVID-19 has caused a major global pandemic and necessitated unprecedented public health restrictions in almost every country. Understanding risk factors for severe disease in hospitalized patients is critical as the pandemic progresses.This observational cohort study aimed to characterize the independent associations between the clinical outcomes of hospitalized patients and their demographics, comorbidities, blood tests and bedside observations. All patients admitted to Northwick Park Hospital, London, United Kingdom between 12 March and 15 April 2020 with COVID-19 were retrospectively identified. The primary outcome was death. Associations were explored using Cox proportional hazards modelling.The study included 981 patients. The mortality rate was 36.0%. Age (adjusted hazard ratio (aHR) 1.53), respiratory disease (aHR 1.37), immunosuppression (aHR 2.23), respiratory rate (aHR 1.28), hypoxia (aHR 1.36), Glasgow Coma Score <15 (aHR 1.92), urea (aHR 2.67), alkaline phosphatase (aHR 2.53), C-reactive protein (aHR 1.15), lactate (aHR 2.67), platelet count (aHR 0.77) and infiltrates on chest radiograph (aHR 1.89) were all associated with mortality.These important data will aid clinical risk stratification and provide direction for further research.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis study received no funding.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:National Research Ethics: REC 20/NW/0218, IRAS 282630)All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesSTATA codes can be obtained from the authors. Data on all COVID-19 admission has already been stared with Public Health England. Application for further patient level data should be addressed to Northwick Park Hospital's research ethics committee. ER -